financetom
Business
financetom
/
Business
/
Research Alert: Cof: Q2 Earnings Beat Following The Successful Acquisition Of Discover
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: Cof: Q2 Earnings Beat Following The Successful Acquisition Of Discover
Jul 22, 2025 2:30 PM

05:10 PM EDT, 07/22/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

COF posted strong Q2 2025 results, with operating EPS of $5.48 vs $3.14 the prior year, beating consensus by $1.76, though revenue of $12.5B missed estimates by 3%. Results were significantly affected by the Discover acquisition, which closed May 18 for $51.8B in an all-stock transaction. The acquisition drove substantial growth, with period-end loans surging 36% Y/Y to $439B and deposits rising 27% Y/Y to $468B, contributing to 32% Y/Y net interest income growth to $10.0B and 69 bps NIM of sequential expansion to 7.62%. COF's allowance coverage ratio increased to 5.43% from 4.91% in Q1, largely due to the acquisition. Capital remained strong, with its CET1 ratio improving 40 bps Q/Q to 14.0% and liquidity coverage ratio at 157%. We believe COF is well positioned to leverage its expanded scale and network following the Discover acquisition, with integration and synergy realization being key focus areas as the company capitalizes on its strengthened market position in credit cards and payment networks.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Applied DNA Sciences (APDN) Stock Is Rising
Why Applied DNA Sciences (APDN) Stock Is Rising
Apr 1, 2025
Applied DNA Sciences Inc ( APDN ) shares are trading higher by 6.0% to $1.76 during Tuesday’s session after the company announced it positioned its TR8 PGx testing as pre-emptive testing for therapeutic safety. What To Know: Applied DNA Sciences ( APDN ) on Tuesday announced that its subsidiary, Applied DNA Clinical Labs (ADCL), is refining its TR8 PGx pharmacogenomics...
Update: MDA Space Down 5% as Says to Acquire NYSE American-listed SatixFy Communications for US$193 Million
Update: MDA Space Down 5% as Says to Acquire NYSE American-listed SatixFy Communications for US$193 Million
Apr 1, 2025
12:03 PM EDT, 04/01/2025 (MT Newswires) -- (Updates shares.) MDA Space ( MDALF ) said Tuesday that it agreed to acquire SatixFy Communications ( SATX ) for US$193 million. MDA will pay US$2.10 per share for SatixFy, which supplies semiconductors and solutions for the space and the satellite communications value chain. Its technology enables satellite broadband and direct-to-device constellations with...
Update: Eli Lilly Reportedly Sues More Drug Compounders for Copying Weight Loss Drug
Update: Eli Lilly Reportedly Sues More Drug Compounders for Copying Weight Loss Drug
Apr 1, 2025
12:00 PM EDT, 04/01/2025 (MT Newswires) -- (Updates with statement from Eli Lilly ( LLY ) spokesperson in the last two paragraphs.) Eli Lilly ( LLY ) is going after two more drug compounders that continue to make and sell copies of its weight loss drug despite a March court order against it, multiple media outlets reported Tuesday. The company's...
Toyota Motor US Sales Rise in March, Q1
Toyota Motor US Sales Rise in March, Q1
Apr 1, 2025
12:03 PM EDT, 04/01/2025 (MT Newswires) -- Toyota Motor's ( TM ) North American unit said Tuesday that US sales in March were up 7.7% on a volume basis to 231,335 compared to a year ago. For Q1, the sales totaled 570,269 vehicles, up 0.9% on a volume basis from the year-ago period. Sales of electrified vehicles for March and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved